Paul Peter Tak, Chief Executive Officer at Candel Therapeutics, Inc. (CADL), sold 43,408 shares at $7.23 ($314K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Open-market sale of $314k CADL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.23 | 21,704 | $157K | 50.0% |
| 2 | $7.23 | 21,704 | $157K | 50.0% |
| Total | $7.23 avg | 43,408 | $314K | 100% |
| Filing → |
| CADL | SELL | 2025-01-10 | $348K | — | Filing → |
| CADL | SELL | 2024-12-03 | $445K | — | Filing → |
| CADL | SELL | 2024-07-19 | $292K | — | Filing → |